![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/histogen-seeks-tear-covid-19-rd-pact-and-go-solo-accuses-amerimmune-failing-push-phase-2
https://www.clinicaltrialsarena.com/news/histogen-amerimmune-covid-drug/
https://www.globenewswire.com/news-release/2021/08/16/2281050/0/en/Histogen-and-Amerimmune-Announce-Additional-Findings-from-its-Phase-1-Study-of-Emricasan-in-Mild-Symptomatic-COVID-19-Patients.html
https://www.globenewswire.com/news-release/2021/05/19/2232422/0/en/Histogen-and-Amerimmune-Report-Publication-on-Emricasan-in-COVID-19.html
https://www.globenewswire.com/news-release/2021/03/16/2193562/0/en/Histogen-and-Amerimmune-Announce-First-Patient-Dosed-in-Phase-1-Study-of-Emricasan-in-Symptomatic-COVID-19-Patients.html#:~:text=(NASDAQ%3A%20HSTO)%20and%20Amerimmune,site%20for%20the%20study%20conduct.